BioCentury
ARTICLE | Company News

Shield Therapeutics sales and marketing update

June 27, 2016 7:00 AM UTC

Shield launched Feraccru ferric maltol in the U.K. to treat adults with iron deficiency anemia associated with inflammatory bowel disease (IBD). The price as agreed to with the U.K.’s Department of H...